Submitted by Anonymous (not verified) on 13 February 2024 - 11:28
Human medicines European public assessment report (EPAR): Rolufta Ellipta (previously Rolufta), umeclidinium, Date of authorisation: 20/03/2017, Revision: 12, Status: Authorised
Source: